Back to top
more

Cardinal Health (CAH)

(Real Time Quote from BATS)

$98.78 USD

98.78
279,660

+0.08 (0.08%)

Updated May 17, 2024 12:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (146 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?

Tandem Diabetes (TNDM) outperforms the industry, owing to its impressive series of product launches and an impressive quarterly performance.

Investors Heavily Search Cardinal Health, Inc. (CAH): Here is What You Need to Know

Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.

Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics

The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View

Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.

What You Should Know About Block (SQ) Ahead of Q1 Earnings

Block's (SQ) first-quarter results are likely to reflect strength across Cash App and Square ecosystems.

What You Should Do With MercadoLibre (MELI) Ahead of Q1 Earnings

MercadoLibre's (MELI) first-quarter 2024 results are likely to reflect strength across e-commerce and fintech businesses.

What's in Store for These 5 Medical Device Stocks in Q1 Earnings?

Here is a sneak peek into how five medical device stocks, BDX, BAX, XRAY, CAH and DVA, might fare in their quarterly results slated to be released tomorrow.

Merit Medical (MMSI) Beats Q1 Earnings and Revenue Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 8.45% and 2.40%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: McKesson (MCK) Q4 Earnings Expected to Decline

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMETEK (AME) to Report Q1 Earnings: What's in the Offing?

AMETEK's (AME) first-quarter results are expected to reflect the benefits of acquisitions despite economic uncertainties.

What's in Store for Cardinal Health (CAH) in Q3 Earnings?

Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.

Should You Buy Booking Holdings (BKNG) Ahead of Q1 Earnings?

Booking Holdings' (BKNG) first-quarter 2024 results are likely to reflect strength in gross bookings, hotel room nights sold, and airline ticket units sold.

Seeking Clues to Cardinal (CAH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.

Should You Consider PayPal (PYPL) Ahead of Q1 Earnings?

PayPal's (PYPL) first-quarter results are expected to reflect gains from its strength in Venmo, checkout experiences and BNPL solutions.

The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp

10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp are included in this Analyst Blog.

Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings

Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.

Here's What You Should Know About EBAY Ahead of Q1 Earnings

EBAY's first-quarter 2024 performance will likely reflect strength across its advertising business amid softness in its active buyer base.

Garmin (GRMN) to Report Q1 Earnings: What's in the Cards?

Garmin's (GRMN) first-quarter 2024 results are likely to reflect growing momentum across Fitness, Outdoor, Marine, Aviation and Auto OEM segments.

Urmimala Biswas headshot

3 Medical Products Stocks Set to Beat This Earnings Season

Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cencora (COR) to Report Q2 Earnings: What's in the Cards?

Cencora's (COR) second-quarter fiscal 2024 results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.

Assessing Super Micro Computer (SMCI) Ahead of Q3 Earnings

Super Micro Computer's (SMCI) third-quarter fiscal 2024 performance will likely reflect strength in the Server & Storage Systems and Subsystems & Accessories segments.

ETSY Gears Up to Report Q1 Earnings: What's in the Cards?

ETSY's first-quarter 2024 earnings are likely to have gained from growing momentum among active buyers and active sellers.